CARDIFF ONCOLOGY INC (CRDF) Stock Earnings & Estimates
USA - NASDAQ:CRDF - US14147L1089 - Common Stock
1.9908 USD
-0.06 (-2.89%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 390K 8.33% | 488K 25.13% | 683K 39.96% | 443.7K -35.04% | 335.325K -24.43% | 81.6K -75.67% | 102K 25.00% | 103.54M 101,409.80% | 315.96M 205.16% | 460.25M 45.67% | 670.49M 45.68% | |
| EBITDA YoY % growth | -39.66M -39.60% | -45.014M -13.50% | -48.247M -7.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.9M -38.25% | -45.412M -13.81% | -48.651M -7.13% | -59.584M -22.47% | -68.754M -15.39% | -92.941M -35.18% | -170.066M -82.98% | -126.725M 25.49% | -19.351M 84.73% | 110.61M 671.60% | 294.01M 165.81% | |
| Operating Margin | -10,230.77% | -9,305.74% | -7,123.13% | -13,428.91% | -20,503.69% | -113,898.34% | -166,731.25% | -122.39% | -6.12% | 24.03% | 43.85% | |
| EPS YoY % growth | -0.89 -25.35% | -0.93 -4.49% | -0.95 -2.15% | -0.85 10.53% | -0.87 -2.64% | -1.12 -28.34% | -1.59 -41.66% | -1.60 -0.96% | -0.32 80.25% | 0.67 312.90% | 1.74 159.09% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 16.51% | -0.22 0.03% | -0.21 -5.06% | -0.22 -3.94% | -0.22 -5.07% | -0.23 -4.35% | -0.22 -6.80% | -0.23 -5.14% | -0.23 -6.98% | -0.24 -6.67% | -0.28 -22.73% | -0.32 -37.78% |
| Revenue Q2Q % growth | 108.375K -34.32% | 108.375K -28.23% | 81.6K -25.14% | 81.6K -32.56% | 81.6K -24.71% | 81.6K -24.71% | 102K 25.00% | 102K 25.00% | 102K 25.00% | 102K 25.00% | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.548M -15.45% | -15.413M -22.60% | -15.579M -8.33% | -15.99M -8.21% | -16.778M -15.33% | -17.593M -14.15% | -18.768M -20.47% | -19.788M -23.75% | -20.808M -24.02% | -21.318M -21.17% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.21 19.23% | -0.20 | -0.01 | -6.95% |
| Q1 2025 Q2Q % growth | -0.20 9.09% | -0.19 | -0.01 | -5.25% |
| Q4 2024 Q2Q % growth | -0.22 -4.76% | -0.25 | 0.03 | 10.75% |
| Q3 2024 Q2Q % growth | -0.25 -13.64% | -0.28 | 0.03 | 9.22% |
| Q2 2024 Q2Q % growth | -0.26 -4.00% | -0.25 | -0.01 | -2.99% |
| Q1 2024 Q2Q % growth | -0.22 12.00% | -0.25 | 0.03 | 12.85% |
| Q4 2023 Q2Q % growth | -0.21 -5.00% | -0.28 | 0.07 | 25.81% |
| Q3 2023 Q2Q % growth | -0.22 -10.00% | -0.29 | 0.07 | 24.32% |
| Q2 2023 Q2Q % growth | -0.25 -4.17% | -0.26 | 0.01 | 5.44% |
| Q1 2023 Q2Q % growth | -0.25 | -0.23 | -0.02 | -8.45% |
| Q4 2022 Q2Q % growth | -0.20 13.04% | -0.24 | 0.04 | 16.56% |
| Q3 2022 Q2Q % growth | -0.20 -17.65% | -0.27 | 0.07 | 25.73% |
| Q2 2022 Q2Q % growth | -0.24 -41.18% | -0.26 | 0.02 | 6.70% |
| Q1 2022 Q2Q % growth | -0.25 -78.57% | -0.24 | -0.01 | -6.10% |
| Q4 2021 Q2Q % growth | -0.23 -21.05% | -0.18 | -0.05 | -31.35% |
| Q3 2021 Q2Q % growth | -0.17 10.53% | -0.17 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.17 66.67% | -0.15 | -0.02 | -11.30% |
| Q1 2021 Q2Q % growth | -0.14 | -0.15 | 0.01 | 6.95% |
| Q4 2020 Q2Q % growth | -0.19 62.75% | -0.14 | -0.05 | -33.05% |
| Q3 2020 Q2Q % growth | -0.19 73.24% | -0.19 | 0.00 | 0.21% |
| Q2 2020 Q2Q % growth | -0.51 35.44% | -0.24 | -0.27 | -108.33% |
| Q4 2019 Q2Q % growth | -0.51 | -0.59 | 0.08 | 13.04% |
| Q3 2019 Q2Q % growth | -0.71 | -0.86 | 0.15 | 17.13% |
| Q2 2019 Q2Q % growth | -0.79 | -0.54 | -0.25 | -46.13% |
| Q1 2019 Q2Q % growth | -1.02 | -1.09 | 0.07 | 6.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 121K -25.77% | 108.375K | 12.625K | 11.65% |
| Q1 2025 Q2Q % growth | 109K -46.83% | 98.359K | 10.641K | 10.82% |
| Q4 2024 Q2Q % growth | 151K -3.21% | 96.053K | 54.947K | 57.20% |
| Q3 2024 Q2Q % growth | 165K 17.02% | 81.6K | 83.4K | 102.21% |
| Q2 2024 Q2Q % growth | 163K 50.93% | 59.925K | 103.075K | 172.01% |
| Q1 2024 Q2Q % growth | 205K 146.99% | 56.1K | 148.9K | 265.42% |
| Q4 2023 Q2Q % growth | 156K 20.00% | 38.25K | 117.75K | 307.84% |
| Q3 2023 Q2Q % growth | 141K 56.67% | 51K | 90K | 176.47% |
| Q2 2023 Q2Q % growth | 108K 20.00% | 51K | 57K | 111.76% |
| Q1 2023 Q2Q % growth | 83K 18.57% | 56.712K | 26.288K | 46.35% |
| Q4 2022 Q2Q % growth | 130K | 74.715K | 55.285K | 73.99% |
| Q3 2022 Q2Q % growth | 90K | 69.564K | 20.436K | 29.38% |
| Q2 2022 Q2Q % growth | 90K 28.57% | 66.096K | 23.904K | 36.17% |
| Q1 2022 Q2Q % growth | 70K | 48.113K | 21.887K | 45.49% |
| Q4 2021 Q2Q % growth | 130K 8.33% | 43.35K | 86.65K | 199.88% |
| Q3 2021 Q2Q % growth | 90K -35.71% | 30.6K | 59.4K | 194.12% |
| Q2 2021 Q2Q % growth | 70K 75.00% | 155.55K | -85.55K | -55.00% |
| Q1 2021 Q2Q % growth | 70K | 155.55K | -85.55K | -55.00% |
| Q4 2020 Q2Q % growth | 120K 33.33% | 33.15K | 86.85K | 261.99% |
| Q3 2020 Q2Q % growth | 140K 180.00% | 33.997K | 106.003K | 311.81% |
| Q2 2020 Q2Q % growth | 40K | 40K | % | |
| Q1 2020 Q2Q % growth | 70K 16.67% | % | ||
| Q4 2019 Q2Q % growth | 90K | 57.63K | 32.37K | 56.17% |
| Q2 2019 Q2Q % growth | 40K | 183.6K | -143.6K | -78.21% |
| Q1 2019 Q2Q % growth | 60K | 176.46K | -116.46K | -66.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.09% | 10.77% | -4.82% | -5.67% |
| Revenue | 0% | 4.5% | 5.55% | 7.67% |